ACIC vs REGN · P/E 4.9, rev $296.7M vs P/E 14, rev $14.34B
American Coastal Insurance Corp (ACIC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
American Coastal Insurance Corp (ACIC) is a insurance - property & casualty company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ACIC revenue for 2024-12-31 was $296.7M. Net income was $75.7M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. ACIC currently screens at market cap $508.4M and trailing P/E 4.9.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ACIC currently screens at market cap $508.4M and trailing P/E 4.9. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ACIC and REGN stock pages for the full models.
Not investment advice.